Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Cancer Treatment Reports
|
September 1, 1982
Persistent hypomagnesemia following cisplatin chemotherapy for testicular cancer
R L Schilsky, A Barlock, R F Ozols
Cancer
|
February 15, 1980
Changes in multiple or sequential estrogen receptor determinations in breast cancer
J C Allegra, A Barlock, K K Huff, et al.
Cancer Treatment Reports
|
September 1, 1979
Chemotherapy for testicular cancer: current status of the National Cancer Institute Combined Modality Trial
T Anderson, N Javadpour, R Schilsky, et al.
Cancer
|
May 15, 1983
Treatment of poor prognosis nonseminomatous testicular cancer with a "high-dose" platinum combination chemotherapy regimen
R F Ozols, A B Deisseroth, N Javadpour, et al.
Cancer
|
July 1, 1979
Estrogen receptor values in patients with benign breast disease
J C Allegra, M E Lippman, L Green, et al.
Lancet (London, England)
|
November 22, 1980
Defective monocyte killing in patients with malignancies and restoration of function during chemotherapy
E S Kleinerman, L A Zwelling, D Howser, et al.
Cancer Research
|
May 1, 1979
Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer
J C Allegra, M E Lippman, E B Thompson, et al.
Cancer Treatment Reports
|
August 1, 1979
Association between steroid hormone receptor status and disease-free interval in breast cancer
J C Allegra, M E Lippman, R Simon, et al.
The New England Journal of Medicine
|
June 1, 1978
The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer
M E Lippman, J C Allegra, E B Thompson, et al.
Cancer Treatment Reports
|
September 1, 1978
Association between steroid hormone receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer
J C Allegra, M E Lippman, E B Thompson, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Cancer Treatment Reports
|
September 1, 1982
Persistent hypomagnesemia following cisplatin chemotherapy for testicular cancer
R L Schilsky, A Barlock, R F Ozols
Cancer
|
February 15, 1980
Changes in multiple or sequential estrogen receptor determinations in breast cancer
J C Allegra, A Barlock, K K Huff, et al.
Cancer Treatment Reports
|
September 1, 1979
Chemotherapy for testicular cancer: current status of the National Cancer Institute Combined Modality Trial
T Anderson, N Javadpour, R Schilsky, et al.
Cancer
|
May 15, 1983
Treatment of poor prognosis nonseminomatous testicular cancer with a "high-dose" platinum combination chemotherapy regimen
R F Ozols, A B Deisseroth, N Javadpour, et al.
Cancer
|
July 1, 1979
Estrogen receptor values in patients with benign breast disease
J C Allegra, M E Lippman, L Green, et al.
Lancet (London, England)
|
November 22, 1980
Defective monocyte killing in patients with malignancies and restoration of function during chemotherapy
E S Kleinerman, L A Zwelling, D Howser, et al.
Cancer Research
|
May 1, 1979
Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer
J C Allegra, M E Lippman, E B Thompson, et al.
Cancer Treatment Reports
|
August 1, 1979
Association between steroid hormone receptor status and disease-free interval in breast cancer
J C Allegra, M E Lippman, R Simon, et al.
The New England Journal of Medicine
|
June 1, 1978
The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer
M E Lippman, J C Allegra, E B Thompson, et al.
Cancer Treatment Reports
|
September 1, 1978
Association between steroid hormone receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer
J C Allegra, M E Lippman, E B Thompson, et al.
Page
of 1